{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:55:27Z","timestamp":1783400127122,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003195","name":"Dutch Ministry of Economic Affairs","doi-asserted-by":"publisher","award":["WOT-01-003-067"],"award-info":[{"award-number":["WOT-01-003-067"]}],"id":[{"id":"10.13039\/501100003195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003195","name":"Dutch Ministry of Economic Affairs","doi-asserted-by":"publisher","award":["KB-21-006-012"],"award-info":[{"award-number":["KB-21-006-012"]}],"id":[{"id":"10.13039\/501100003195","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejpb.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T06:16:18Z","timestamp":1539065778000},"page":"85-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge"],"prefix":"10.1016","volume":"133","author":[{"given":"Jasmine","family":"Tomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin","family":"Biel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis A.M.","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.M.","family":"Rottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4459-9874","authenticated-orcid":false,"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henderik W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-5245","authenticated-orcid":false,"given":"Anke","family":"Huckriede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter L.J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.10.008_b0005","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)60493-6","article-title":"Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China","volume":"371","author":"Wang","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2018.10.008_b0010","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(13)60903-4","article-title":"Al., Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome","volume":"381","author":"Chen","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2018.10.008_b0015","doi-asserted-by":"crossref","first-page":"20838","DOI":"10.2807\/1560-7917.ES2014.19.25.20838","article-title":"Limited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013","volume":"19","author":"Zhu","year":"2014","journal-title":"Eurosurveillance"},{"issue":"2004","key":"10.1016\/j.ejpb.2018.10.008_b0020","first-page":"2088","article-title":"Avian influenza a virus (H7N7) epidemic in The Netherlands in 2003: course of the epidemic and effectiveness of control measures","volume":"190","author":"Stegeman","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejpb.2018.10.008_b0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cimid.2007.07.004","article-title":"Influenza vaccines and vaccination strategies in birds","volume":"31","author":"van den Berg","year":"2008","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejpb.2018.10.008_b0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.vetimm.2011.05.023","article-title":"A lack of antibody formation against inactivated influenza virus after aerosol vaccination in presence or absence of adjuvantia","volume":"143","author":"De Geus","year":"2011","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1208\/s12248-010-9179-z","article-title":"Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures","volume":"12","author":"Geeraedts","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2018.10.008_b0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2010.02.025","article-title":"A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation","volume":"144","author":"Saluja","year":"2010","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2018.10.008_b0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ejpb.2013.07.018","article-title":"Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants","volume":"85","author":"Murugappan","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.10.008_b0050","article-title":"Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination","volume":"0584","author":"Tomar","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ejpb.2018.10.008_b0055","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1016\/j.vaccine.2014.09.048","article-title":"Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus","volume":"32","author":"Peeters","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0060","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/AEM.72.1.880-889.2006","article-title":"Novel surface display system for proteins on non-genetically modi gram-positive bacteria","volume":"72","author":"Bosma","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymeth.2005.09.015","article-title":"Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria","volume":"38","author":"van Roosmalen","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.ejpb.2018.10.008_b0070","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.vaccine.2006.09.026","article-title":"Development of lactococcal GEM-based pneumococcal vaccines","volume":"25","author":"Audouy","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0075","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.vaccine.2006.02.040","article-title":"Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations","volume":"24","author":"Ramasamy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/s12248-009-9168-2","article-title":"Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant","volume":"12","author":"Saluja","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2018.10.008_b0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/mi.2009.131","article-title":"Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection","volume":"3","author":"Ramirez","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0090","unstructured":"N. Petrovsky, P.D. Cooper, Advax\u2122, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety 33 (2015) 367\u2013402."},{"key":"10.1016\/j.ejpb.2018.10.008_b0095","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/glycob\/cwq201","article-title":"Delta inulin: a novel, immunologically active, stable packing structure comprising \u03b2-D-[2 \u2192 1] poly(fructo-furanosyl) \u03b1d-glucose polymers","volume":"21","author":"Cooper","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejpb.2018.10.008_b0100","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.vaccine.2012.12.077","article-title":"A novel hepatitis B vaccine containing Advax\u2122, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing","volume":"31","author":"Saade","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0105","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/JVI.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0110","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.vaccine.2015.01.062","article-title":"A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax\u2122 delta inulin adjuvant induces robust T-cell protection against listeria infection","volume":"33","author":"Rodriguez-Del Rio","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0120","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.vaccine.2011.06.078","article-title":"Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets","volume":"29","author":"Layton","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13567-014-0130-7","article-title":"Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals","volume":"45","author":"Bielefeldt-Ohmann","year":"2014","journal-title":"Vet. Res."},{"key":"10.1016\/j.ejpb.2018.10.008_b0130","unstructured":"D.L. Gordon, D. Sajkov, et al., Randomized clinical trial of immunogenicity and safety of a recombinant H1N1\/2009 pandemic influenza vaccine containing Advax\u2122 polysaccharide adjuvant 30 (2012) 5407\u20135416."},{"key":"10.1016\/j.ejpb.2018.10.008_b0135","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/j.vaccine.2014.09.034","article-title":"Immunogenicity and safety of Advax\u2122, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen; a randomized controlled Phase 1 study","volume":"32","author":"Gordon","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0140","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1016\/j.vaccine.2011.04.029","article-title":"Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization","volume":"29","author":"Audouy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/10717544.2018.1435748","article-title":"Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus","volume":"25","author":"Bhide","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2018.10.008_b0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/03079450500268476","article-title":"Development of a lavage procedure to collect lung secretions from chickens for evaluating respiratory humoral immunity","volume":"34","author":"Holt","year":"2005","journal-title":"Avian Pathol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2307\/1365930","article-title":"Respiratory and heart rates of birds at rest","volume":"70","author":"Calder","year":"1968","journal-title":"Condor"},{"key":"10.1016\/j.ejpb.2018.10.008_b0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/1591084","article-title":"Lung volume of meat-type chickens","volume":"33","author":"Julian","year":"1989","journal-title":"Avian Dis."},{"key":"10.1016\/j.ejpb.2018.10.008_b0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vetmic.2010.06.012","article-title":"The effect of inoculation dose of a highly pathogenic avian influenza virus strain H5N1 on the infectiousness of chickens","volume":"147","author":"Spekreijse","year":"2011","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2017.01.012","article-title":"Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: consequences for vaccine strain selection","volume":"503","author":"Peeters","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.ejpb.2018.10.008_b0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2008.08.037","article-title":"Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine","volume":"382","author":"van der Goot","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.ejpb.2018.10.008_b0180","doi-asserted-by":"crossref","first-page":"e52135","DOI":"10.1371\/journal.pone.0052135","article-title":"Enhancement of the immunogenicity and protective efficacy of a mucosal influenza subunit vaccine by the saponin adjuvant GPI-0100","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.10.008_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030898","article-title":"Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity","volume":"7","author":"Budimir","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.10.008_b0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1637\/7427-082605R.1","article-title":"An aerosolized fluorescent microsphere technique for evaluating particle deposition in the avian respiratory tract","volume":"50","author":"Tell","year":"2006","journal-title":"Avian Dis."},{"key":"10.1016\/j.ejpb.2018.10.008_b0195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/03079450601028845","article-title":"Deposition of differently sized airborne microspheres in the respiratory tract of chickens","volume":"35","author":"Corbanie","year":"2006","journal-title":"Avian Pathol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/01652176.2012.711956","article-title":"Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines","volume":"32","author":"de Geus","year":"2012","journal-title":"Vet. Q."},{"key":"10.1016\/j.ejpb.2018.10.008_b0205","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2011.05.014","article-title":"Immunogenicity of low-pH treated whole viral influenza vaccine","volume":"417","author":"Quan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.ejpb.2018.10.008_b0210","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3389\/fimmu.2018.01815","article-title":"An improved inactivated influenza vaccine with enhanced cross protection","volume":"9","author":"Ni","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2018.10.008_b0215","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.vaccine.2014.02.019","article-title":"Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion","volume":"32","author":"Keijzer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2014.10.008","article-title":"Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant","volume":"66","author":"Murugappan","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.10.008_b0225","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1016\/j.vaccine.2012.04.032","article-title":"Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration","volume":"30","author":"de Haan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.10.008_b0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2018.09.006","article-title":"Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge","volume":"288","author":"Tomar","year":"2018","journal-title":"J. Control. Release."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118308063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118308063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T03:08:51Z","timestamp":1542424131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118308063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"alternative-id":["S0939641118308063"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.10.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}